Richard Kowalski, Ph.D. is the Chief Scientist and Principal Investigator at ASELL. Dr. Kowalski has over 30 years of experience developing and supporting in vitro diagnostic devices including confirmatory assays for HIV, HTLV-I/II, and Lyme disease along with IDE experience using mesenchymal stem cells for bone repair, cancer treatment, and gene therapy and platelet-rich plasma support for wound care. Prior to joining ASELL, Dr. Kowalski led Medical and Clinical Affairs teams and early Product Development at Cylex Inc. As lead of Product Development at Cylex, Dr. Kowalski brought the Cylex Immune Cell Function Assay (ImmuKnow®) from bench to bedside by leading the clinical and analytical validation studies to support clearance of ImmuKnow for marketing in the US. Dr. Kowalski provides ASELL the experience required to validate the safety and efficacy of high-complexity assays and detection systems. Dr. Kowalski received his doctorate in Molecular Biology at Vanderbilt University.